Forever Labs, a pioneer in stem cell banking and regenerative medicine in Ann Arbor, has announced the formal spinout of SuperShot Inc. as an independent company.
Concurrent with this strategic move, the board has appointed Kevin Virgil as the new CEO of Forever Labs.
Forever Labs is a consumer health care company that operates America’s only ISO-certified adult stem cell processing laboratory. The company enables clients to store their stem cells for potential future use in treating age-related risk factors, injuries, and other chronic diseases.
SuperShot Inc. develops innovative platelet-rich plasma (PRP) therapeutic interventions. Founded as a spinout from Forever Labs, the company is led by Steven Clausnitzer and Mark Katakowski.
The spinout enables both companies to focus on their core missions while maintaining strong collaborative ties. Forever Labs’ founders, Clausnitzer and Katakowski, will lead SuperShot Inc., while Virgil will helm Forever Labs as it works to develop innovations in stem cell preservation and therapeutics.
“This spinout represents a natural evolution for both companies,” says Clausnitzer. “SuperShot has reached a stage where it deserves dedicated leadership and resources. We’re incredibly excited to focus our energies on SuperShot.”
Katakowski, chief science officer at Forever Labs, says the two companies “have created significant and distinct opportunities. This strategic separation enables each company to maximize its potential, and realize its unique vision.”
Virgil, the new CEO, brings entrepreneurial experience to his new role at Forever Labs, having previously founded and scaled a data analytics company. As a longtime client of Forever Labs, Virgil has firsthand appreciation for the company’s mission and potential.
“I’ve been passionate about Forever Labs since I first became a client,” says Virgil. “We are positioned at the forefront of a revolution in longevity medicine and metabolic health, and I’m committed to building on the incredible foundation that Steven and Mark have established.”
The leadership transition and company spinout are effective immediately. Both companies will continue to operate from their current locations, while maintaining their respective research partnerships and customer commitments.
For more information, visit foreverlabs.com/.
